Less guesswork, more support with Smart MDI

Get personalized dosing guidance with the InPenTM smart insulin pen with SimpleraTM CGM.†

Get started

Reorder InPen
InPen with Simplera system

Actionable insights with Smart MDI

MiniMed Champion Jennifer Stone injecting InPen in stomach

For people who manage their diabetes with multiple daily injections (MDI), this system can help relieve the mental effort that comes with regular insulin injections.
Integrating our new SimpleraTM CGM, InPenTM smart insulin pen, and an intuitive app, this Smart MDI system provides you with:

  • Personalized dosing recommendations
  • Missed meal dose alerts
  • High glucose correction notifications
  • Dose calculator

Smart MDI system components

InPenTM smart insulin pen

Add icon collapse icon

A reusable smart insulin pen that uses Bluetooth® to send data to an app, making it easier to track insulin doses and manage your diabetes.

Animation of blue InPen

SimpleraTM  CGM

Add icon collapse icon

Our small, easy-to-use, all-in-one sensor, supported by a dedicated app, provides real-time glucose readings.

  • A simple, two-step insertion process
  • A disposable inserter
  • No overtape required
Simplera sensor

Mobile apps

Add icon collapse icon

The InPenTM app seamlessly connects to the SimpleraTM app and works like a digital logbook, automatically tracking your dosing data on your phone and sending actionable insights to create a unified experience.

Extended infusion set

Get started with InPen today!

Interested in learning more? Please complete the form below or call 1-800-646-4633 and select option 3 (Monday - Friday, 8:00 a.m. CT to 7:00 p.m. CT) and one of our Diabetes Therapy Specialists will be happy to assist you.

Pay as little as $60 per InPen per year!

indicates a required field.

Are you an existing MiniMed customer?
This field is required.

Check your upgrade eligibility

Follow these 3 simple steps:

  1. Sign into your account at www.diabetes.shop/devices
  2. Under Devices and products, select the “Check upgrade eligibility” button.
  3. See which program you're eligible for and then submit an upgrade request!

Check eligibility or upgrade >
This field is required.
This field is required.
This field is required.

You indicated that you’re not using insulin to manage your diabetes. Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:


If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.

You indicated that you’re not using insulin to manage your diabetes. Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:


If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.
This field is required.

Thank you for being a MiniMed customer. Please sign in to your Diabetes.shop account to see the upgrade options available for you. Submit the Request form within your account and you will be notified about next steps to upgrade.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.

This form is for customers in the Unites States only. For more information about our products in your region please see our list of international locations.

How can we communicate with you?
This field is required.

I have read and understood the terms of this marketing authorization. I authorize Medtronic to use my protected health information for the purposes described in the authorization.

HIPAA MARKETING AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

MiniMed* respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with MiniMed representatives and contractors.  

Please note that this Authorization is optional, and you may refuse to opt in.  If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLinkTM Personal system, or other MiniMed products, mobile apps, or services. You will be provided with a copy of this Authorization after it is acknowledged.

This Authorization will expire ten (10) years from the date you submit this authorization online but may expire sooner if required by applicable law, or if you remove it by following one of the methods below:

    1. Email takecontrol@medtronic.com
    2. Sign in to the Profile page and update your communication preferences
        at www.Diabetes.shop/communication
    3. Contact Customer Service Center at 800-646-4633

Opting out will not affect actions MiniMed has already taken based on this Authorization. Information disclosed pursuant to this Authorization may be re-disclosed by the recipient of the information and may no longer be protected by federal privacy standards. If you have additional questions about this Authorization, please contact our Customer Service Center at 800-646-4633 or by email at takecontrol@medtronic.com.

Please review our Notice of Privacy Practices and Privacy Statement or contact our support team to get details on how MiniMed processes your personal data, the involvement of affiliates and third-party data processors, cross-border transfer, and your rights as a data subject.

*MiniMed Distribution Corp. and Medtronic MiniMed, Inc. are “Medtronic Diabetes”
This field is required.

I agree to receive phone calls and/or artificial prerecorded marketing voice messages sent from or on behalf of MinMed using automated technology at the phone number(s) I have provided.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of MiniMed products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for MiniMed to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).
This field is required.

I agree to receive marketing SMS text communications using automated technology sent from or on behalf of MiniMed at the mobile phone number(s) I have provided (message frequency may vary).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of MiniMed products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for MiniMed to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).
This field is required.

If you arrived on this site via a social media platform, by submitting this form you agree that Medtronic Diabetes may share your visit to this site with that platform. This information may be used and/or re-disclosed by the originating site under their own privacy practices. See our Privacy Policy for more information. Click here to request information without submitting this form.

Thank you!

We’ve received your request – we’ll be in touch with product information soon.

Oops!

Something went wrong. Please try again later.

Focus more on your life and less on diabetes management

Living with diabetes requires a lot of extra decisions every day. A traditional insulin pen allows you to dial doses and deliver insulin, but our system is a smarter way to MDI! See how they compare.

Smart MDI system

Traditional insulin pen
Allows for half-unit dosing
Yes

Available with some brands
Reusable device that uses insulin cartridges
Yes

Available with some brands
Uses Bluetooth® to log and track insulin dosing
Yes
No
Provides missed dose detection and alerts
Yes
No
Detects high glucose and sends correction notification
Yes
No
Pairs with an app that has a dose calculator
Yes
No
Keeps track of insulin on board
Yes
No
Provides temperature alerts so you'll know if your insulin gets too hot
Yes
No
Can generate reports that can be emailed to your healthcare team
Yes
No

Footnotes

† Products sold separately.

Important Safety Information: InPen system

The InPen system consists of a reusable insulin pen and mobile app and is for people living with diabetes. It can be used to deliver insulin, help calculate insulin doses, and estimate carbohydrates for meals. Those under the age of 7 should only use the device with an adult’s supervision. A healthcare provider must prescribe InPen, provide dosage settings, and discuss all potential benefits and risks. Using the device with incorrect therapy settings may lead to severe highs and lows. The system should not be used by those unable to test blood glucose levels or the visually impaired. For additional product and important safety information, see https:www.minimed.com/en-us/important-safety-information.html#smart-pen-system

Important Safety Information: SimpleraTM system
The SimpleraTM system requires a prescription. It consists of a sensor and mobile app that perform real-time continuous glucose monitoring (CGM) for the management of diabetes in adults ages 18 years and older. The sensor is indicated for up to 6 days of use, plus an additional grace period of 24 hours. It is intended for use in home environments. The Simplera™ system does not require calibration. Blood glucose (BG) readings are required (1) during the first 12 hours of use, (2) if no sensor data is available, (3) when symptoms do not match the sensor glucose (SG) value, and (4) when taking certain medications. Not taking BG readings as indicated can lead to incorrect SG readings, over-administration of insulin, and possible hypoglycemia.

The SimpleraTM app in combination with the Simplera™ sensor is intended for use only by patients and caregivers using a compatible mobile device and operating system, and who have sufficient experience to adjust mobile device audio and notification settings. When taking any of the following medications, consult a healthcare professional prior to using the system, as these can bias SG readings, potentially leading to the over-administration of insulin and a higher risk of hypoglycemia: acetaminophen, paracetamol, hydroxyurea, hydroxycarbamide. Sensor use can also result in skin irritation, bruising, discomfort, redness, bleeding, and infection, and sensors in general also pose a choking risk to young children. For complete details, consult the user guides and important safety information.